Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

株式のランク #3229
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
株価
$33.33
最終同期: 2026-10-19
時価総額
$5.50B
変化(1日)
-0.68%
変化(1年)
52.16%
国
IN
取引 Gland Pharma Limited (GLAND)

カテゴリー

Healthcare
Gland Pharma Limited(GLAND)の営業利益率
October 2026 時点の営業利益率 TTM: 19.59%
Gland Pharma Limited の最新の財務報告と株価によると、現在の営業利益率(TTM)は 19.59% です。2024 年末時点では 32.17% でした。
Gland Pharma Limited の営業利益率の履歴(2017 から 2026)
各年末の営業利益率
年 営業利益率 変化
2026 (TTM) 19.59% -36.68%
2025 30.94% -3.82%
2024 32.17% 30.67%
2023 24.62% -22.89%
2022 31.93% -7.26%
2021 34.43% 2.87%
2020 33.47% 6.83%
2019 31.33% 8.03%
2018 29.00% -23.12%
2017 37.72% 0.00%
同業他社の営業利益率
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。